Among the validation sets, the sensitivity and specificity of the AMH recommended threshold (≤2.18 ng/mL) for predicting EPL in non-PCOS women were 85.00% and 78.63%, respectively, with an overall prediction accuracy of 78.80%. This evidence concerns the gene AMH and polycystic ovary syndrome.